Meitav Investment House’s Moderna MRNA Stock Holding History

Meitav Investment House’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.38M	Sell	27,143 -16,067	-37%	-$750K	0.02%	148
2025 Q4	$1.27M	Hold	43,210	–	–	0.01%	162
2025 Q3	$1.12M	Hold	43,210	–	–	0.01%	161
2025 Q2	$1.19M	Hold	43,210	–	–	0.02%	142
2025 Q1	$1.23M	Buy	43,210 +350	+0.8%	+$12.4K	0.02%	124
2024 Q4	$1.78M	Sell	42,860 -184,043	-81%	-$8.8M	0.03%	114
2024 Q3	$15.2M	Buy	226,903 +111,475	+97%	+$10.2M	0.25%	71
2024 Q2	$13.7M	Sell	115,428 -51,978	-31%	-$6.58M	0.24%	70
2024 Q1	$17.8M	Buy	167,406 +96	+0.1%	+$9.68K	0.35%	66
2023 Q4	$16.6M	Buy	167,310 +16	+0%	+$1.35K	0.24%	87
2023 Q3	$16.9M	Buy	167,294 +12,189	+8%	+$1.36M	0.27%	84
2023 Q2	$18.9M	Hold	155,105	–	–	0.3%	83
2023 Q1	$20.8M	Buy	155,105 +132,259	+579%	+$21.8M	0.36%	77
2022 Q4	$4.1M	Hold	22,846	–	–	0.07%	151
2022 Q3	$2.7M	Buy	22,846 +65	+0.3%	+$9.86K	0.05%	177
2022 Q2	$3.25M	Buy	22,781 +7,839	+52%	+$1.12M	0.06%	166
2022 Q1	$2.57M	Buy	+14,942	New	+$2.52M	0.04%	200

Other funds holding MRNA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return